Richard H. Bell

19.1k total citations · 3 hit papers
167 papers, 7.4k citations indexed

About

Richard H. Bell is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Richard H. Bell has authored 167 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Oncology, 45 papers in Surgery and 23 papers in Molecular Biology. Recurrent topics in Richard H. Bell's work include Pancreatic and Hepatic Oncology Research (28 papers), HER2/EGFR in Cancer Research (22 papers) and Bone health and treatments (15 papers). Richard H. Bell is often cited by papers focused on Pancreatic and Hepatic Oncology Research (28 papers), HER2/EGFR in Cancer Research (22 papers) and Bone health and treatments (15 papers). Richard H. Bell collaborates with scholars based in United States, Australia and United Kingdom. Richard H. Bell's co-authors include Thomas E. Adrian, David Cameron, Marina Talamonti, Robert J. Hye, L. D. Britt, Marshall J. Orloff, Thomas W. Biester, Robert S. Rhodes, Frank R. Lewis and Mustafa Khasraw and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Richard H. Bell

159 papers receiving 7.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1996 780 citations James R. Berenson, Alan Lichtenstein et al. New England Journal of Medicine profile →
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

2017 688 citations David Cameron, Martine Piccart et al. The Lancet profile →
13-cis-Retinoic Acid in the Treatment of Oral Leukoplakia

1986 633 citations Richard H. Bell et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard H. Bell United States	40	3.5k	2.1k	1.5k	1.0k	967	167	7.4k
Timothy Perren United Kingdom	42	3.0k 0.9×	1.3k 0.6×	1.4k 0.9×	452 0.4×	902 0.9×	151	6.6k
Hemming Johansson Sweden	44	4.4k 1.3×	2.3k 1.1×	790 0.5×	633 0.6×	1.2k 1.2×	186	7.6k
Katherine S. Virgo United States	50	4.7k 1.3×	2.5k 1.2×	1.1k 0.7×	823 0.8×	3.1k 3.2×	203	10.9k
Harry Comber Ireland	32	3.2k 0.9×	1.6k 0.7×	1.2k 0.8×	460 0.4×	1.9k 2.0×	103	7.0k
Thomas J. Herzog United States	64	3.2k 0.9×	3.3k 1.6×	1.8k 1.2×	407 0.4×	1.3k 1.3×	334	13.3k
Lynette M. Smith United States	53	2.9k 0.8×	1.1k 0.5×	2.1k 1.4×	464 0.5×	1.3k 1.3×	299	8.8k
Chun Chieh Lin United States	27	4.2k 1.2×	1.4k 0.7×	2.5k 1.6×	613 0.6×	2.4k 2.5×	100	9.9k
Allan Hackshaw United Kingdom	50	2.3k 0.6×	1.9k 0.9×	1.3k 0.8×	386 0.4×	1.7k 1.8×	202	10.7k
Jourik A. Gietema Netherlands	56	3.5k 1.0×	2.4k 1.2×	3.0k 1.9×	1.5k 1.5×	2.1k 2.1×	252	10.1k
Paul Sabbatini United States	45	4.0k 1.1×	1.5k 0.7×	1.8k 1.2×	426 0.4×	1.9k 1.9×	182	8.8k

Countries citing papers authored by Richard H. Bell

Since Specialization

Citations

This map shows the geographic impact of Richard H. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard H. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard H. Bell more than expected).

Fields of papers citing papers by Richard H. Bell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard H. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard H. Bell. The network helps show where Richard H. Bell may publish in the future.

Co-authorship network of co-authors of Richard H. Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Richard H. Bell. A scholar is included among the top collaborators of Richard H. Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard H. Bell. Richard H. Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goel, Shom, Jia Liu, Hao Guo, et al.. (2019). Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity. JACC Heart Failure. 7(9). 795–804. 30 indexed citations

Cameron, David, Martine Piccart, Richard D. Gelber, et al.. (2017). 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. The Lancet. 389(10075). 1195–1205. 688 indexed citations breakdown →

Wilcken, Nicholas, Nicholas Zdenkowski, Michelle White, et al.. (2014). Systemic treatment of HER2‐positive metastatic breast cancer: A systematic review. Asia-Pacific Journal of Clinical Oncology. 10(S4). 1–14. 17 indexed citations

Boer, Richard de, Jane Beith, Jacquie Chirgwin, et al.. (2014). Systemic treatment of HER2+ metastatic breast cancer: Clinical conundrums and future perspectives. Asia-Pacific Journal of Clinical Oncology. 10(S4). 15–25. 1 indexed citations

Metzger, Otto, Marion Procter, Evandro de Azambuja, et al.. (2013). Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial. Journal of Clinical Oncology. 31(16). 1954–1960. 30 indexed citations

Bilous, Michael, Adrienne Morey, Jane E. Armes, et al.. (2012). Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program. Breast Cancer Research and Treatment. 134(2). 617–624. 28 indexed citations

Farshid, Gelareh, Jane E. Armes, Richard H. Bell, et al.. (2010). Establishment of the Australian In Situ Hybridization Program for the Assessment of HER2 Amplification in Breast Cancer. Diagnostic Molecular Pathology. 19(4). 187–193. 11 indexed citations

Bell, Richard H., et al.. (2008). The impact of the HIPAA Privacy Rule on collegiate sport professionals. The Sport Journal. 11(2). 1 indexed citations

Varghese, Thomas K. & Richard H. Bell. (2007). Duodenum-preserving head resection for chronic pancreatitis: an institutional experience and national survey of usage. Surgery. 142(4). 588–593.e3. 17 indexed citations

10.

Baselga, José, Edith A. Perez, Tadeusz Pieńkowski, & Richard H. Bell. (2006). Adjuvant Trastuzumab: A Milestone in the Treatment of HER-2-Positive Early Breast Cancer. The Oncologist. 11(S1). 4–12. 166 indexed citations

11.

Killingsworth, Richard, Audrey de Nazelle, & Richard H. Bell. (2003). A NEW ROLE FOR PUBLIC HEALTH IN TRANSPORTATION CREATING AND SUPPORTING COMMUNITY MODELS FOR ACTIVE TRANSPORTATION. 13(1). 1 indexed citations

12.

Bell, Richard H.. (2002). What Can We Learn from Herceptin<sup>®</sup> Trials in Metastatic Breast Cancer?. Oncology. 63(Suppl. 1). 39–46. 34 indexed citations

13.

Bell, Richard H.. (2000). Surgical options in the patient with chronic pancreatitis. Current Gastroenterology Reports. 2(2). 146–151. 10 indexed citations

14.

Bell, Richard H., Layton F. Rikkers, & Michael W. Mulholland. (1996). Digestive tract surgery : a text and atlas. 12 indexed citations

15.

Berenson, James R., Alan Lichtenstein, Lester Porter, et al.. (1996). Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma. New England Journal of Medicine. 334(8). 488–493. 780 indexed citations breakdown →

16.

Orloff, Marshall J., Marshall J. Orloff, Richard H. Bell, et al.. (1994). Prospective Randomized Trial of Emergency Portacaval Shunt and Emergency Medical Therapy in Unselected Cirrhotic Patients With Bleeding Varices. Hepatology. 20(4). 863–872. 36 indexed citations

17.

Bell, Richard H.. (1993). Simone Weil's philosophy of culture : readings toward a divine humanity. Cambridge University Press eBooks. 11 indexed citations

18.

Bell, Richard H.. (1985). Elephants and woodland: a reply [letter to the editor]. Pachyderm. 5. 17–18. 3 indexed citations

19.

Bell, Richard H.. (1968). The origin of Islam in its Christian environment : the Gunning lectures, Edinburgh University 1925. 1 indexed citations

20.

Bell, Richard H.. (1961). A study of the image of the American character as presented in the selected network television dramas /. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact